106 related articles for article (PubMed ID: 7344949)
1. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
Sizemore GW; Hpeath H; Larson JM
J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
[TBL] [Abstract][Full Text] [Related]
5. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
6. Medullary thyroid carcinoma and calcitonin.
Emmertsen K
Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical heterogeneity of calcitonin in plasma.
Deftos LJ; Roos BA; Bronzert D; Parthemore JG
J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
[TBL] [Abstract][Full Text] [Related]
8. Immunoextracted calcitonin in milk and plasma from totally thyroidectomized women. Evidence of monomeric calcitonin in plasma during pregnancy and lactation.
Bucht E; Telenius-Berg M; Lundell G; Sjöberg HE
Acta Endocrinol (Copenh); 1986 Dec; 113(4):529-35. PubMed ID: 3788423
[TBL] [Abstract][Full Text] [Related]
9. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
10. A new bioactive form of human calcitonin.
Tobler PH; Dambacher MA; Born W; Heitz PU; Maier R; Fischer JA
Cancer Res; 1983 Aug; 43(8):3793-9. PubMed ID: 6861143
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.
Tobler PH; Tschopp FA; Dambacher MA; Born W; Fischer JA
J Clin Endocrinol Metab; 1983 Oct; 57(4):749-54. PubMed ID: 6885964
[TBL] [Abstract][Full Text] [Related]
12. Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man.
Body JJ; Heath H
J Clin Endocrinol Metab; 1983 Nov; 57(5):897-903. PubMed ID: 6413526
[TBL] [Abstract][Full Text] [Related]
13. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
Myhre L; Gautvik KM
Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
[TBL] [Abstract][Full Text] [Related]
14. Molecular weight forms of immunoreactive calcitonin in a patient with medullary carcinoma of the thyroid: dynamic studies with calcium, pentagastrin and somatostatin.
Bertagna XY; Bloomgarden ZT; Rabin D; Roberts LJ; Orth DN
Clin Endocrinol (Oxf); 1980 Aug; 13(2):115-23. PubMed ID: 6108170
[TBL] [Abstract][Full Text] [Related]
15. Pituitary immunoreactive calcitonin-like material: lack of evidence for cross-reactivity with pro-opiomelanocortin.
Gagel RF; O'Briain DS; Voelkel EF; Wolfe HJ; DeLellis RA; Lee AK; Tashjian AH
Metabolism; 1983 Jul; 32(7):686-96. PubMed ID: 6191178
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic polypeptide immunoreactivity in medullary carcinoma of the thyroid: identification and characterisation by radioimmunoassay, immunocytochemistry and high performance liquid chromatography.
O'Hare MM; Shaw C; Johnston CF; Russell CF; Sloan JM; Buchanan KD
Regul Pept; 1986 Apr; 14(2):169-80. PubMed ID: 2872701
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin in extrathyroidal tissues of man.
Becker KL; Snider RH; Moore CF; Monoghan KG; Silva OL
Acta Endocrinol (Copenh); 1979 Dec; 92(4):746-51. PubMed ID: 532527
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
